Skip to main content
PMC home page
Gut logoLink to Gut
. 2000 Mar;46(3):415–419. doi: 10.1136/gut.46.3.415

Diagnosis of Wilson's disease: an experience over three decades

P Gow 1, R Smallwood 1, P Angus 1, A Smith 1, A Wall 1, R Sewell 1
PMCID: PMC1727845  PMID: 10673307

Abstract

BACKGROUND—Wilson's disease is a rare but treatable condition that often presents diagnostic dilemmas. These dilemmas have for the most part not been resolved by the identification and cloning of the Wilson's disease gene.
AIMS—To report our experience over three decades with patients with Wilson's disease in order to illustrate the diverse patterns of presentation and thereby broaden the approach to diagnosis.
METHODS—Clinical and laboratory findings of 30 patients with Wilson's disease were reviewed.
RESULTS—Twenty two patients presented with liver manifestations (eight with fulminant hepatic failure and 14 with chronic liver disease), three with neurological disease, and one with haemolysis; four were asymptomatic siblings of patients with Wilson's disease. Seventy per cent were diagnosed within six months of the onset of symptoms, but diagnosis was delayed for up to nine years. Age range at diagnosis was wide (7-58 years) and five patients were over 40. In patients presenting with non-fulminant disease, 18% had neither Kayser-Fleischer rings nor low caeruloplasmin concentrations. Increased liver copper concentrations were found in all but one patient who had undergone six years of penicillamine treatment. In fulminant hepatic failure (n=8) additional features helpful in the diagnosis included evidence of haemolysis, increased urinary copper (range 844-9375 µg/24 h), and a high non-caeruloplasmin copper (range 325-1743 µg/l).
CONCLUSIONS—The diagnosis of Wilson's disease still depends primarily on the evaluation of clinical and laboratory evidence of abnormal copper metabolism. No one feature is reliable, but the diagnosis can usually be made provided that it is suspected. Wilson's disease should be considered in patients of any age with obscure hepatic or neurological abnormalities.


Keywords: Wilson's disease; diagnosis; liver; fulminant hepatic failure

Full Text

The Full Text of this article is available as a PDF (107.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams P. C., Campion M. L., Gandon G., LeGall J. Y., David V., Jouanolle A. M. Clinical and family studies in genetic hemochromatosis: microsatellite and HFE studies in five atypical families. Hepatology. 1997 Oct;26(4):986–990. doi: 10.1002/hep.510260428. [DOI] [PubMed] [Google Scholar]
  2. Berman D. H., Leventhal R. I., Gavaler J. S., Cadoff E. M., Van Thiel D. H. Clinical differentiation of fulminant Wilsonian hepatitis from other causes of hepatic failure. Gastroenterology. 1991 Apr;100(4):1129–1134. doi: 10.1016/0016-5085(91)90294-u. [DOI] [PubMed] [Google Scholar]
  3. Bull P. C., Thomas G. R., Rommens J. M., Forbes J. R., Cox D. W. The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nat Genet. 1993 Dec;5(4):327–337. doi: 10.1038/ng1293-327. [DOI] [PubMed] [Google Scholar]
  4. Danks D. M., Metz G., Sewell R., Prewett E. J. Wilson's disease in adults with cirrhosis but no neurological abnormalities. BMJ. 1990 Aug 11;301(6747):331–332. doi: 10.1136/bmj.301.6747.331. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Frydman M., Bonné-Tamir B., Farrer L. A., Conneally P. M., Magazanik A., Ashbel S., Goldwitch Z. Assignment of the gene for Wilson disease to chromosome 13: linkage to the esterase D locus. Proc Natl Acad Sci U S A. 1985 Mar;82(6):1819–1821. doi: 10.1073/pnas.82.6.1819. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Houwen R. H., Roberts E. A., Thomas G. R., Cox D. W. DNA markers for the diagnosis of Wilson disease. J Hepatol. 1993 Mar;17(3):269–276. doi: 10.1016/s0168-8278(05)80204-1. [DOI] [PubMed] [Google Scholar]
  7. Iser J. H., Stevens B. J., Stening G. F., Hurley T. H., Smallwood R. A. Hemolytic anemia of Wilson's disease. Gastroenterology. 1974 Aug;67(2):290–293. [PubMed] [Google Scholar]
  8. Kingston H. M., Jassie L. B. Microwave energy for acid decomposition at elevated temperatures and pressures using biological and botanical samples. Anal Chem. 1986 Oct;58(12):2534–2541. doi: 10.1021/ac00125a038. [DOI] [PubMed] [Google Scholar]
  9. Maier-Dobersberger T., Mannhalter C., Rack S., Granditsch G., Kaserer K., Korninger L., Steindl P., Gangl A., Ferenci P. Diagnosis of Wilson's disease in an asymptomatic sibling by DNA linkage analysis. Gastroenterology. 1995 Dec;109(6):2015–2018. doi: 10.1016/0016-5085(95)90771-8. [DOI] [PubMed] [Google Scholar]
  10. Martins da Costa C., Baldwin D., Portmann B., Lolin Y., Mowat A. P., Mieli-Vergani G. Value of urinary copper excretion after penicillamine challenge in the diagnosis of Wilson's disease. Hepatology. 1992 Apr;15(4):609–615. doi: 10.1002/hep.1840150410. [DOI] [PubMed] [Google Scholar]
  11. Mason J., McQuaid A., Pheiffer H. Can Wilson's disease patients be decoppered? Lancet. 1989 Jun 24;1(8652):1455–1455. doi: 10.1016/s0140-6736(89)90165-7. [DOI] [PubMed] [Google Scholar]
  12. McCullough A. J., Fleming C. R., Thistle J. L., Baldus W. P., Ludwig J., McCall J. T., Dickson E. R. Diagnosis of Wilson's disease presenting as fulminant hepatic failure. Gastroenterology. 1983 Jan;84(1):161–167. [PubMed] [Google Scholar]
  13. McDonald J. A., Snitch P., Painter D., Hensley W., Gallagher N. D., McCaughan G. W. Striking variability of hepatic copper levels in fulminant hepatic failure. J Gastroenterol Hepatol. 1992 Jul-Aug;7(4):396–398. doi: 10.1111/j.1440-1746.1992.tb01007.x. [DOI] [PubMed] [Google Scholar]
  14. Rosenberg E. B., Strickland G. T., Feng Y. S., Blackwell R. Q. Comparison of immunologic and enzymatic methods for ceruloplasmin quantitation in Wilson's disease. Taiwan Yi Xue Hui Za Zhi. 1971 Jan 28;70(1):49–53. [PubMed] [Google Scholar]
  15. Schilsky M. L., Sternlieb I. Overcoming obstacles to the diagnosis of Wilson's disease. Gastroenterology. 1997 Jul;113(1):350–353. [PubMed] [Google Scholar]
  16. Shah A. B., Chernov I., Zhang H. T., Ross B. M., Das K., Lutsenko S., Parano E., Pavone L., Evgrafov O., Ivanova-Smolenskaya I. A. Identification and analysis of mutations in the Wilson disease gene (ATP7B): population frequencies, genotype-phenotype correlation, and functional analyses. Am J Hum Genet. 1997 Aug;61(2):317–328. doi: 10.1086/514864. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Steindl P., Ferenci P., Dienes H. P., Grimm G., Pabinger I., Madl C., Maier-Dobersberger T., Herneth A., Dragosics B., Meryn S. Wilson's disease in patients presenting with liver disease: a diagnostic challenge. Gastroenterology. 1997 Jul;113(1):212–218. doi: 10.1016/s0016-5085(97)70097-0. [DOI] [PubMed] [Google Scholar]
  18. Sternberg J. C. A rate nephelometer for measuring specific proteins by immunoprecipitin reactions. Clin Chem. 1977 Aug;23(8):1456–1464. [PubMed] [Google Scholar]
  19. Sternlieb I. Perspectives on Wilson's disease. Hepatology. 1990 Nov;12(5):1234–1239. doi: 10.1002/hep.1840120526. [DOI] [PubMed] [Google Scholar]
  20. Sternlieb I., Scheinberg I. H. The role of radiocopper in the diagnosis of Wilson's disease. Gastroenterology. 1979 Jul;77(1):138–142. [PubMed] [Google Scholar]
  21. Stremmel W., Meyerrose K. W., Niederau C., Hefter H., Kreuzpaintner G., Strohmeyer G. Wilson disease: clinical presentation, treatment, and survival. Ann Intern Med. 1991 Nov 1;115(9):720–726. doi: 10.7326/0003-4819-115-9-720. [DOI] [PubMed] [Google Scholar]
  22. Strickland G. T., Frommer D., Leu M. L., Pollard R., Sherlock S., Cumings J. N. Wilson's disease in the United Kingdom and Taiwan. I. General characteristics of 142 cases and prognosis. II. A genetic analysis of 88 cases. Q J Med. 1973 Jul;42(167):619–638. [PubMed] [Google Scholar]
  23. Tanzi R. E., Petrukhin K., Chernov I., Pellequer J. L., Wasco W., Ross B., Romano D. M., Parano E., Pavone L., Brzustowicz L. M. The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene. Nat Genet. 1993 Dec;5(4):344–350. doi: 10.1038/ng1293-344. [DOI] [PubMed] [Google Scholar]
  24. Thomas G. R., Forbes J. R., Roberts E. A., Walshe J. M., Cox D. W. The Wilson disease gene: spectrum of mutations and their consequences. Nat Genet. 1995 Feb;9(2):210–217. doi: 10.1038/ng0295-210. [DOI] [PubMed] [Google Scholar]
  25. WALSHE J. M., BRIGGS J. Caeruioplasmin in liver disease. A diagnostic pitfall. Lancet. 1962 Aug 11;2(7250):263–265. doi: 10.1016/s0140-6736(62)90171-x. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES